-
De Novo Donor-Specific Antibody Development in Heart Transplant Recipients Following COVID-19 Vaccination
-
De Novo Donor-Specific Antibody Development with Mycophenolate versus Azathioprine in Lung Transplant Recipients
-
De Novo DSA in the Setting of Stable Allograft Function is a Benign Finding
-
De Novo Fibrinogen Alpha Chain Amyloidosis in Kidney Allograft
-
De Novo Focal Segmental Glomerulosclerosis in the Kidney Allograft: Association with Alloimmunity Leading to Poor Outcome
-
De Novo Lipoprotein-X Causing Hypercholesterolemia and Acute Kidney Injury (AKI) in Simultaneous Liver Kidney Transplant (SLKT) Patient
-
De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation
-
De-Novo Belatacept Therapy is Associated with Higher Levels of BK Viremia and Lower Rates of BK Clearance in Kidney Transplantation Patients
-
Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs
-
Deceased Donor Organ Flush with Similar Volumes of HTK and UW at a Single U.S. Organ Procurement Organization: Adult and Pediatric Data
- « Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 190
- Next Page »